PSI
PDLI

Pinnacle Summer Investments’s PDL BioPharma, Inc. PDLI Stock Holding History

Pinnacle Summer Investments’s Portfolio PDLI Stock Details PDLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$0 Buy
+546
New +$2.29K ﹤0.01% 1132

Other funds holding PDLI

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pinnacle Summer Investments's PDLI Position: Q4 2015 in Review

Pinnacle Summer Investments opened a new position in PDL BioPharma, Inc. (PDLI) in Q4 2015: 546 shares worth $0. The stake represents ﹤0.01% of the portfolio and ranks #1132 among its holdings.

204 funds tracked by Wall St. Rank hold PDLI as of Q4 2015.

  • Pinnacle Summer Investments held 546 shares of PDL BioPharma, Inc. worth $0 as of Q4 2015.
  • PDL BioPharma, Inc. was a new Pinnacle Summer Investments position in Q4 2015.
  • PDL BioPharma, Inc. made up ﹤0.01% of Pinnacle Summer Investments's portfolio in Q4 2015, its #1132 holding.
  • 204 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2015.

Based on Pinnacle Summer Investments's 13F filing for Q4 2015, filed 16 Feb 2016.